Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0002084547-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-03-04	2026-03-02	ELV	Craig Ryan R	EVP, Chief HR Off	A - Grant	$0.00	+2,976	6,983	+74%	$0
DM	2026-03-04	2026-03-02+	ELV	Craig Ryan R	EVP, Chief HR Off	F - Tax	$284.78	-334	4,007	-8%	-$95.1K
D	2026-03-04	2026-03-02	ELV	Craig Ryan R	EVP, Chief HR Off	A - Grant	$0.00	+11.8K	11.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-02	A	A	2,976	$0.00	6,983	D	—	—	(F2) Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
2	Common	Common Stock	2026-03-03	F	D	309	$284.03	6,674	D	—	—	(F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
3	Common	Common Stock	2026-03-02	F	D	25	$294.07	4,007	D	—	—	(F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
4	Derivative	Employee Stock Option (Right to Buy)	2026-03-02	A	A	11,754	$0.00	11,754	D	$294.07 · 2036-03-02 to —	11,754 Common Stock	(F3) The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.